| Pharmaceutical Information |
| Drug Name |
Cefuroxime |
| Drug ID |
BADD_D00407 |
| Description |
Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus. |
| Indications and Usage |
For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections. |
| Marketing Status |
Prescription |
| ATC Code |
J01DC02; S01AA27 |
| DrugBank ID |
DB01112
|
| KEGG ID |
D00262
|
| MeSH ID |
D002444
|
| PubChem ID |
41375
|
| TTD Drug ID |
D0Y2IE
|
| NDC Product Code |
0143-9567; 0143-9977; 0143-9569; 0143-9979; 0143-9976; 0143-9568 |
| Synonyms |
Cefuroxime | Cephuroxime | Zinacef | Ketocef |
|
| Chemical Information |
| Molecular Formula |
C16H16N4O8S |
| CAS Registry Number |
55268-75-2 |
| SMILES |
CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
